Page 181 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

61. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontam- (PRORATA trial): a multicentre randomised controlled trial.
ination for control of nosocomial multiresistant gram-negative Lancet. 2010;375:463-474.
bacilli: study of an outbreak in an intensive care unit. Ann Intern 77. Micek, ST, Ward S, Fraser VJ, et al. A randomized controlled trial
Med. 1989;110:873-881. of an antibiotic discontinuation policy for clinically suspected
62. Boyce JM, Potter-Bynoe G, Chenevert C, et al. Environmental ventilator-associated pneumonia. Chest. 2004;125:1791-1799.
contamination due to methicillin-resistant Staphylococcus 78. Pittet D, Mourouga P, Perneger TV Compliance with hand-
aureus: possible infection control implications. Infect Control washing in a teaching hospital. Infection Control Program. Ann
Hosp Epidemiol. 1997;18:622-627. Intern Med. 1999;130(2):126-130.
63. Gerner-Smidt P. Endemic occurrence of Acinetobacter calco- 79. Eckmanns T, Bessert J, Behnke M, et al. Compliance with
aceticus biovar anitratus in an intensive care unit. J Hosp Infect. antiseptic hand rub use in intensive care units: the Hawthorne
1987;10:265-272. effect. Infect Control Hosp Epidemiol. 2006;27(9):931-934.
64. Coello R, Jimenez J, Garcia M, et al. Prospective study of 80. Harbarth S, Sudre P, Dharan S, et al. Outbreak of Enterobacter
infection, colonization and carriage of methicillin-resistant cloacae related to understaffing, overcrowding, and poor hygiene
Staphylococcus aureus in an outbreak affecting 990 patients. Eur practices. Infect Control Hosp Epidemiol. 1999;20:598-603.
J Clin Microbiol Infect Dis. 1994;13:74-81. 81. Hugonnet S, Perneger TV, Pittet D. Alcohol-based handrub
65. Chaix C, Durand-Zaleski I, Alberti C, et al. Control of endemic improves compliance with hand hygiene in intensive care units.
methicillin-resistant Staphylococcus aureus: a cost-benefit anal- Arch Intern Med. 2002;162:1037-1043.
ysis in an intensive care unit. JAMA. 1999;282:1745-1751. 82. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily
66. Siegel J, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection bathing with chlorhexidine on the acquisition of methicillin-resis-
Control Practices Advisory Committee. Management of multi- tant Staphylococcus aureus, vancomycin-resistant Enterococcus,
drug-resistant organisms in healthcare settings, 2006. http:// and healthcare-associated bloodstream infections: results of a
www.cdc.gov/ncidod/dhqp/pdf/ar/MDROGuideline2006.pdf. uasi-experimental multicenter trial. Crit Care Med. 2009;37(6):
Accessed September 23, 2010. 1858-1865.
67. Infection PreventionWorking Party. MRSA hospital. January 83. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for
2007. http://www.wip.nl/UK/contentbrowser/onderwerpsort.asp isolation precautions: preventing transmission of infectious
?exprcap1&exppap1&expowp22&sortbyptitel&sortdnp0#HIER. agents in healthcare settings. http://www.cdc.gov/hicpac/pdf/
Accessed September 23, 2010. isolation/Isolation2007.pdf. Accessed September 23, 2010.
84. Jernigan JA, Titus MG, Groschel DH, et al. Effectiveness of con-
68. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent tact isolation during a hospital outbreak of methicillin-resistant
transmission of methicillin-resistant Staphylococcus aureus in Staphylococcus aureus. Am J Epidemiol. 1996;143:496-504.
acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(suppl
1):S62-S80. 85. Werner BG, Grady GF. Accidental hepatitis-B-surface-antigen-
positive inoculations: use of e antigen to estimate infectivity.
69. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screen- Ann Intern Med. 1982;97:367-369.
ing for methicillin-resistant Staphylococcus aureus at hospital
admission and nosocomial infection in surgical patients. JAMA. 86. Centers for Disease Control and Prevention (CDC). Case-
2008;299(10):1149-1157. control study of HIV seroconversion in health-care workers
after percutaneous exposure to HIV-infected blood—France,
70. Huan SS, Septimus EI, Kleinman K, et al. CDC Prevention United Kingdom, and United States, January 1988–August
Epicenters Program and AHRQ DECIDE Network. Targeted 1994. MMWR. 1995;44:929-933.
versus universal colonization to prevent ICU infection. New Eng
J Med. 2013;368:2255-2265. 87. Greenaway C, Menzies D, Fanning A, et al. Delay in diagnosis
among hospitalized patients with active tuberculosis—predictors
71. Ibrahim EH, Sherman G, Ward S, et al. The influence of inad- and outcomes. Am J Respir Crit Care Med. 2002;165:927-933.
equate antimicrobial treatment of bloodstream infections on 88. Guidelines for preventing the transmission of Mycobacterium
patient outcomes in the ICU setting. Chest. 2000;118(1):146-155.
tuberculosis in health-care facilities, 1994. Centers for Disease
72. Singh N, Rogers P, Atwood CW, et al. Short-course empiric Control and Prevention. MMWR Recomm Rep. 1994;43:1-132.
antibiotic therapy for patients with pulmonary infiltrates in the 89. Takimoto CH, Cram DL, Root RK. Respiratory syncytial
intensive care unit: a proposed solution for indiscriminate antibi- virus infections on an adult medical ward. Arch Intern Med.
otic prescription. Am J Respir Crit Care Med. 2000;162:505-511. 1991;151:706-708.
73. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days 90. Garcia R, Raad I, Abi-Said D, et al. Nosocomial respiratory syncy-
of antibiotic therapy for ventilator-associated pneumonia in tial virus infections: prevention and control in bone marrow trans-
adults: a randomized trial. JAMA. 2003;290(19):2588-2598. plant patients. Infect Control Hosp Epidemiol. 1997;18:412-416.
74. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious 91. Gehanno JF, Kohen-Couderc L, Lemeland JF, et al. Nosocomial
Diseases Society of America and the Society for Healthcare meningococcemia in a physician. Infect Control Hosp Epidemiol.
Epidemiology of America guidelines for developing an insti- 1999;20:564-565.
tutional program to enhance antimicrobial stewardship. Clin 92. Wu HM, Harcourt BH, Hatcher CP, et al. Emergence of cipro-
Infect Dis. 2007;44(2):159-177. floxacin-resistant Neisseria meningitidis in North America. N
75. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted Engl J Med. 2009;360(9):886-892.
management program for antibiotics and other anti-infective 93. Interim Recommendations for Infection Control in Health-
agents. N Engl J Med. 1998;338:232-238. Care Facilities Caring for Patients with Known or Suspected
76. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to Avian Influenza. http://www.cdc.gov/flu/avian/professional/
reduce patients’ exposure to antibiotics in intensive care units infect-control.htm. Accessed September 23, 2010.

Section01-O-ref.indd 3 12/10/2014 8:06:38 PM